Pav's Feed
Sep 30, 2011

TMX’s Kloet says too soon for decision on Maple bid

TORONTO, Sept 30 (Reuters) – TMX Group (X.TO: Quote, Profile, Research, Stock Buzz), Canada’s
largest stock exchange operator, has had several meetings with
hostile suitor Maple Group, and has not yet made a decision on
whether it will support Maple’s C$3.8 billion ($3.7 billion)
takeover bid, Chief Executive Thomas Kloet said.

Kloet said in an interview with Reuters on Friday that a
friendly deal was only possible if regulators support the Maple
plan, and that it is impossible to say how long the regulatory
review process will take.

Sep 29, 2011

Maple Group extends TMX takeover bid to Oct. 31

TORONTO, Sept 29 (Reuters) – The Maple Group consortium of
Canadian financial institutions has extended its takeover bid
for Canada’s largest stock market operator for a second time as
it awaits regulatory rulings that could still be months away.

Maple, made up of four of Canada’s largest banks, four top
pension funds and one of North America’s largest life insurers,
said on Thursday, a day before its bid was set to expire, that
it had extended its hostile C$3.8 billion ($3.65 billion) offer
for TMX Group (X.TO: Quote, Profile, Research, Stock Buzz) to Oct. 31.

Sep 28, 2011

Yellow Media to take C$2.9 bln charge, shares dive

Sept 28 (Reuters) – Yellow Media Inc (YLO.TO: Quote, Profile, Research, Stock Buzz) said on
Wednesday it would take a C$2.9 billion ($2.8 billion) charge
in the third quarter, driving its shares down by more than 50
percent in the latest blow to the debt-laden Canadian telephone
directory publisher.

Yellow also said it will stop paying dividends after its
October payment as it struggles to switch from print to a
digital platform, while trying to manage its debt. The company
gets about three-quarters of its revenue from selling
advertisements in its Yellow Pages and related business
directories.

Sep 26, 2011

Valeant to offer C$88 mln for Afexa, tops Paladin

TORONTO, Sept 25 (Reuters) – Acquisition-hungry Valeant
Pharmaceuticals International (VRX.TO: Quote, Profile, Research, Stock Buzz) said on Monday it plans
to raise its takeover offer for Afexa Life Sciences (FXA.TO: Quote, Profile, Research, Stock Buzz) to
C$88 mln ($85.4 million), topping Paladin Labs’ hostile bid for
the maker of Cold-FX flu medicine.

Valeant’s proposal to buy Afexa shares at 85 Canadian cents
each came hours after Paladin raised its offer to 81 Canadian
cents, underscoring the intensity of the race by the
pharmaceutical companies to acquire approved and marketable
drugs.

Sep 22, 2011

Zarlink accepts sweetened Microsemi takeover bid

By John McCrank and Pav Jordan

(Reuters) – Microsemi Corp (MSCC.O: Quote, Profile, Research, Stock Buzz) has reached a friendly agreement to buy Canadian specialty chipmaker Zarlink Semiconductor Inc (ZL.TO: Quote, Profile, Research, Stock Buzz), ending a hostile standoff with a sweetened deal worth $632 million that will bolster Microsemi’s medical technology product portfolio.

California-based Microsemi, which has courted Zarlink since January, said it will pay C$3.98 for each Zarlink share, or 19 percent more than its earlier C$3.35 bid, which Zarlink had rejected.

Sep 16, 2011

Homburg REIT to acquire Quebec property portfolio

TORONTO, Sept 16 (Reuters) – Homburg Canada Real Estate
Investment Trust (HCR_u.TO: Quote, Profile, Research, Stock Buzz) said on Friday it agreed to buy a
portfolio of 29 neighborhood shopping centers in Quebec for
C$114.9 million ($116.7 million) as it expands in the
French-speaking province.

The properties, 26 of which are located in the greater
Montreal area, are anchored by Canadian pharmacy chain the Jean
Coutu Group (PJCa.TO: Quote, Profile, Research, Stock Buzz), and are to be acquired from a group led
by Delek Global Real Estate (DGRE).

Sep 7, 2011

Mosaid asks shareholders to reject Wilan hostile bid

TORONTO, Sept 7 (Reuters) – Mosaid Technologies (MSD.TO: Quote, Profile, Research, Stock Buzz) on
Wednesday asked shareholders to reject a hostile, C$480 million
takeover bid from WiLan Inc (WIN.TO: Quote, Profile, Research, Stock Buzz) after the patent licensing
company’s board said the offer was inadequate.

Ottawa-based Mosaid said it might pursue higher bids for
the company after investors digest its acquisition last week of
a huge portfolio of Nokia (NOK1V.HE: Quote, Profile, Research, Stock Buzz) and Microsoft (MSFT.O: Quote, Profile, Research, Stock Buzz)
patents.

Sep 2, 2011

Microsemi says could walk away from Zarlink bid

TORONTO, Sept 2 (Reuters) – Microsemi Corp (MSCC.O: Quote, Profile, Research, Stock Buzz) has
dared Canada’s Zarlink Semiconductor (ZL.TO: Quote, Profile, Research, Stock Buzz) to show it can get
a takeover bid higher than the C$550 million ($561 million) the
U.S. chipmaker has offered, and said it is willing to walk away
from the bid.

Microsemi, which has bought nine other companies since
2009, has offered C$3.35 a share for Ottawa-based Zarlink, and
the bid expires Sept. 22. Zarlink, a specialty chipmaker, says
it has held talks with 15 potential suitors and that they will
likely yield a higher offer.

Sep 1, 2011

Zarlink says it expects higher takeover offer

TORONTO (Reuters) – Specialty chipmaker Zarlink Semiconductor said on Thursday it expects a white knight to best a hostile C$550 million ($561 million) takeover offer from U.S. rival Microsemi, and is in talks with at least 15 potential buyers.

Zarlink said third parties were interested in buying either part or all of the Ottawa-based company, which designs computer chips for communications and medical applications.

Sep 1, 2011

Zarlink says confident it will get higher offer

TORONTO, Sept 1 (Reuters) – Zarlink Semiconductor (ZL.TO: Quote, Profile, Research, Stock Buzz),
the specialty chipmaker fighting a hostile C$550 million ($561
million) takeover bid by U.S. rival Microsemi (MSCC.O: Quote, Profile, Research, Stock Buzz), has
engaged other parties and is confident of receiving a higher
offer, it said on Thursday.

Ottawa-based Zarlink, which designs mixed-signal chip
technology for communications and medical applications, also
recommended that shareholders reject Microsemi’s C$3.35 a share
bid, which it insists is opportunistic.